Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
HEALTH
Biotech Movers: Epizyme, Alexion, XBiotech
By Armie Margaret Lee
Jun 14, 2017 12:22 PM EDT
PRESS RELEASES
XBiotech Data Shows Effective Anti-Virus Activity For True Human Antibodies In Its Candidate Influenza-COVID-19 Therapeutic Cocktail
By GlobeNewswire
Nov 19, 2020 8:15 AM EST
PRESS RELEASES
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
By GlobeNewswire
Aug 24, 2020 8:10 AM EDT
PRESS RELEASES
XBiotech Discovers COVID-19 Candidate Therapy
By GlobeNewswire
Aug 17, 2020 8:20 AM EDT
PRESS RELEASES
XBiotech Achieves Milestone For Production Of Its New Potential Blockbuster Anti-IL-1⍺ Therapy
By GlobeNewswire
Jul 22, 2020 9:20 AM EDT
PRESS RELEASES
XBiotech Announces Discovery That Blocking Interleukin-1a Reduces Brain Injury And Neurological Deficit After Stroke
By GlobeNewswire
Jul 14, 2020 9:25 AM EDT
PRESS RELEASES
XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺)
By GlobeNewswire
Apr 14, 2020 9:15 AM EDT
PRESS RELEASES
XBiotech And BioBridge Global Collaborate On FDA Program To Develop Potential COVID-19 Treatment Based On Natural Antibodies From Recovered Patients
By GlobeNewswire
Apr 3, 2020 4:53 PM EDT
PRESS RELEASES
XBiotech Announces Final Results Of Tender Offer
By GlobeNewswire
Feb 19, 2020 8:15 AM EST
PRESS RELEASES
Corrected Press Release: XBiotech Announces Preliminary Results Of Tender Offer
By GlobeNewswire
Feb 13, 2020 1:24 PM EST
PRESS RELEASES
XBiotech Announces Preliminary Results Of Tender Offer
By GlobeNewswire
Feb 13, 2020 8:15 AM EST
PRESS RELEASES
XBiotech Commences Tender Offer To Purchase Up To $420,000,000 Of Its Shares
By GlobeNewswire
Jan 14, 2020 8:30 AM EST
HEALTH
Biotech Movers: Epizyme, Alexion, XBiotech
By Armie Margaret Lee
Jun 14, 2017 12:22 PM EDT
HEALTH
Biotech Movers: Coherus, XBiotech, Flexion
By Armie Margaret Lee
Jun 12, 2017 9:22 AM EDT
HEALTH
Biotech Movers: Minerva, XBiotech, Aduro
By Armie Margaret Lee
Jun 1, 2017 9:50 AM EDT
HEALTH
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
By Armie Margaret Lee
May 19, 2017 9:16 AM EDT
STOCKS
XBiotech No. 2 Executive Resigns, Leaving Struggling Biotech Without Top Operations Chief
By Adam Feuerstein
May 11, 2017 8:31 AM EDT
HEALTH
Biotech Movers: XBiotech, Atara, Bellicum
By Armie Margaret Lee
Apr 21, 2017 9:34 AM EDT
STOCKS
XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection
By Adam Feuerstein
Apr 21, 2017 8:00 AM EDT
STOCKS
XBiotech: Four Staph Patients Died in Our Clinical Trial, Nothing to Worry About
By Adam Feuerstein
Apr 3, 2017 12:45 PM EDT
STOCKS
XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
By Adam Feuerstein
Mar 27, 2017 1:18 PM EDT
STOCKS
Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
By Adam Feuerstein
Jul 29, 2016 7:01 AM EDT
STOCKS
XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group
By Adam Feuerstein
Jul 14, 2016 10:18 PM EDT
STOCKS
XBiotech cancer drug survival claim falls apart under scrutiny
By Adam Feuerstein
Jul 5, 2016 8:35 AM EDT
OPINION
8 biotech stocks under $10 poised for breakouts
By Roberto Pedone
Feb 12, 2016 6:44 AM EST
